THE PHYSIOLOGICAL AND BIOCHEMICAL UNDERSTANDING OF 5’-AMP INDUCED DEEP HYPOMETABOLISM by O\u27Brien, William G
Texas Medical Center Library
DigitalCommons@The Texas Medical Center
UT GSBS Dissertations and Theses (Open Access) Graduate School of Biomedical Sciences
12-2009
THE PHYSIOLOGICAL AND
BIOCHEMICAL UNDERSTANDING OF 5’-
AMP INDUCED DEEP HYPOMETABOLISM
William G. O'Brien
Follow this and additional works at: http://digitalcommons.library.tmc.edu/utgsbs_dissertations
Part of the Biochemistry Commons
This Dissertation (PhD) is brought to you for free and open access by the
Graduate School of Biomedical Sciences at DigitalCommons@The Texas
Medical Center. It has been accepted for inclusion in UT GSBS
Dissertations and Theses (Open Access) by an authorized administrator of
DigitalCommons@The Texas Medical Center. For more information,
please contact laurel.sanders@library.tmc.edu.
Recommended Citation
O'Brien, William G., "THE PHYSIOLOGICAL AND BIOCHEMICAL UNDERSTANDING OF 5’-AMP INDUCED DEEP
HYPOMETABOLISM" (2009). UT GSBS Dissertations and Theses (Open Access). Paper 5.
THE PHYSIOLOGICAL AND BIOCHEMICAL UNDERSTANDING OF 5’-AMP 
INDUCED DEEP HYPOMETABOLISM 
by 
William Gerard O’Brien III, B.S.  
 
 
APPROVED: 
 
 
 
______________________________ 
Cheng Chi Lee, Ph.D. 
Supervisory Professor 
 
 
 
______________________________ 
Michael R. Blackburn, Ph.D. 
 
 
 
______________________________ 
William P. Dubinsky, Ph.D. 
 
 
 
______________________________ 
Rodney E. Kellems, Ph.D. 
 
 
 
______________________________ 
Henry W. Strobel, Ph.D. 
APPROVED: 
 
____________________________ 
George Stancel, Ph.D.  
Dean, The University of Texas 
Health Science Center at Houston 
Graduate School of Biomedical Sciences 
THE PHYSIOLOGICAL AND BIOCHEMICAL UNDERSTANDING OF 5’-AMP 
INDUCED DEEP HYPOMETABOLISM 
 
A 
THESIS 
 
Presented to the Faculty of  
The University of Texas  
Health Science Center at Houston  
and 
The University of Texas 
M. D. Anderson Cancer Center 
Graduate School of Biomedical Sciences  
in Partial Fulfillment 
of the Requirements 
for the Degree of 
MASTER OF SCIENCE 
 
by 
 
William Gerard O’Brien III, B.S.  
Houston, Texas 
December, 2009 
   iii 
Acknowledgement 
 First and foremost, I would like to thank my advisor and mentor, Dr. Cheng Chi Lee, 
for his continual support throughout the years; whether it was through intellectually 
stimulating my interests, his financial commitment to support my research or the personal 
touch that comes with being a great mentor. I feel like I have grown immensely in my time 
here and I owe that to his guidance and the lessons I have learned through his teachings.  
 Next, I would like to thank my committee members for being a great help in all 
aspects of my life; Dr. Michael Blackburn, Dr. Rodney Kellems, Dr. Henry Strobel and Dr. 
William Dubinsky. Their support and guidance has also helped teach me many lessons that 
have made me a better person both professionally and personally. 
 Thirdly, I would like to thank all past and current lab members who I have had the 
luxury and pleasure to share a working space with. Dr. Zhaoyang Zhao, Dr. Zhenyin Tao, 
Dr. Jing Zhang, Dr. Takao Miki, Dr. Misty Chen-Goodspeed, Susan Daniels, Tomoko Miki 
and Anita Van Oort-Jansen for their professionalism, willingness to pass along their 
knowledge and also their friendship that make coming to lab an absolute pleasure.  
 Lastly and most importantly, I have to thank the people that have been with me over 
the years, through thick and thin, that have helped me become me. My family (Gerry, Patty, 
Sean and Jeff) is the best family I could ever dream of having in my life and I thank them 
for their enduring support, unconditional love and never-wavering faith in me. Also, my 
group of friends who have been by my side for many years and who continually support me 
and are there for me especially when I need them most. I am blessed to have people like all 
of you in my life and I owe all of you the biggest, sincerest THANK YOU! Love you all! 
  iv 
THE PHYSIOLOGICAL AND BIOCHEMICAL UNDERSTANDING OF 5’-AMP 
INDUCED DEEP HYPOMETABOLISM 
Publication No.________ 
William Gerard O’Brien III, B.S.  
Supervisory Professor: Cheng Chi Lee, Ph.D. 
Our laboratory’s ability to induce deep hypometabolism (DH) via an injection of 
adenosine monophosphate (5’-AMP) followed by placement in an ambient temperature (Ta) 
around 15
o
C currently can last about 3-9 hours.  While we have insight into how 5’-AMP 
induced hypometabolism is initiated, it remains unclear how arousal from hypometabolism 
is controlled. Other laboratory members have been unable to prolong this process safely and 
effectively with previous attempts of re-injecting a dose of 5’-AMP upon arousal or by 
decreasing the Ta. While these methods worked in suppressing arousal, the mortality rate is 
also increased. To gather a better understanding of the process, a metabolic panel from 
serum samples was run giving insight into possible biochemical events occurring from 
euthermia to DH to spontaneous arousal and back to euthermia. Analyzing this data revealed 
many changes in metabolites.  A few metabolites that stood out such as glucose and 
pyruvate did not alter the outcome in arousal rate over saline injection. Additional 
metabolite analysis revealed that an amino acid, arginine, was significantly reduced during 
DH. This amino acid seems to be a key component in prolonging our process possibly due to 
its intricate role in the urea cycle. Supplemental arginine is clearly more beneficial both in 
suppressing arousal and increasing the survival rate after 12 hours in DH.  
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CHAPTER ONE 
Introduction 
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Animals are most commonly segregated into two categories: warm- and cold-
blooded. Warm-blooded animals such as mammals and birds (also known as endotherms) 
maintain their core body temperature at an optimally efficient degree, and for humans this is 
98.6oF or 37oC. In contrast, the core body temperature of cold-blooded animals such as 
reptiles and amphibians (also known as ectotherms) will fluctuate over a range, depending in 
part on their environmental temperature. For humans and other endotherms, this 
maintenance comes at an enormous energy cost compared to similarly sized ectotherms 
(Heldmaier et al., 2004; Else and Hubert, 1981). Mammals large and small alike go 
through daily sleep and awake cycles, during which the metabolic rate and body temperature 
drop slightly when resting (Heldmaier et al., 2004). However this drop is miniscule (less 
than 1oC) compared to the reduction that occurs in daily torpor or hibernation (Lyman, 
1982; Geiser and Ruf, 1995).  Animals that enter hibernation go through a prolonged 
hypometabolic state, which allows their body temperature to drop to around that of their 
environment (Heldmaier et al., 2004). For some hibernators, such as the arctic ground 
squirrel, the core body temperature at hibernation is just above freezing (Barnes 1989). 
Similarly, there are animals that undergo daily bouts of torpor, which is a less severe form of 
hypometabolic state that results in a lowering of the core body temperature (Lyman, 1982). 
Both hibernation and torpor involve the same 4 stages: entrance into hibernation/torpor, 
maintenance at the sub-basal metabolic rate, arousal from the deep hypometabolism, and a 
period at euthermia (Heldmaier et al., 2004). Another commonality between daily torpor 
and hibernation is that as these animals are ready to end their hypometabolic state, their 
bodies start the gradual rewarming process (arousal) that returns the body to euthermic 
temperature and normal metabolic activity (Heldmaier et al., 2004). The difference 
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between the hibernation and the torpor states lies in the second phase (maintenance) or the 
amount of time spent being metabolically depressed; hibernators can exist for days or even 
weeks at a time, whereas animals undergoing torpor fluctuate between normal function and 
the hypometabolic state daily (Geiser and Ruf, 1995). In other words, torpor is a daily, less 
severe form of hypometabolism. These physiological conditions have been observed in most 
of the mammalian orders in both small and large animals, from bats to lemurs to squirrels 
(Heldmaier et al., 2004; Carroll, 1997).  The lemurs are old world primates and they are 
known to hibernate during periods of metabolic stress (Kobbe et al., 2009). Since humans 
are also primates it should be possible for humans to undergo either daily torpor and/or 
hibernation, but if/how this is possible is unknown (Heldmaier et al., 2004; Carroll, 1997). 
The reason we study these processes is to unlock the benefits of hypometabolism so that 
they can be applied to non-hibernating mammals like humans. The possibilities are vast; this 
research could potentially help with anything from increasing the survival rates in trauma 
patients by reducing their body’s metabolic need, to reducing metabolic disorders such as 
obesity by changing the preferred fuel source from glucose in euthermia to fats in 
hibernation, to something as remote as revolutionizing space travel by allowing the transport 
of humans in the hypometabolic state (Andrews, 2007). Also, understanding and exploiting 
hibernation in humans could be the answer to that which people covet most: the fountain of 
youth (Lyman et al., 1981). It has been suggested that hibernation could have similar 
benefits to prolonging life as seen by the practice of caloric restriction (Andrews, 2007). 
Unfortunately, for the most part, the process of hibernation is not well understood and is still 
being extensively researched.  
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Our laboratory has discovered that a naturally produced metabolite, 5’adenosine 
monophosphate (5’-AMP), can be used to induce a torpor-like state in mice without any 
apparent relation to either size or sex of the animal (Zhang et al., 2006). By injecting 0.5 
mg/gram body weight (mg/gw) of 5’-AMP and placing the mice into an incubator with an 
ambient temperature (Ta) around 15oC, the mice will remain in this deep hypometabolic 
state anywhere between 3-9 hours. The reason for the range in the amount of time down is 
due to the fact that the arousal process from this hypometabolic state appears to be 
completely spontaneous. Attempts by other investigators in the laboratory to extend this 
hypometabolic process were largely unsuccessful due to high mortality rate.  Approaches to 
extend the length of this hypometabolic process include increased dosage of 5’-AMP or 
additional injections of 5’-AMP when animals were about to arouse. Increasing the dose of 
5’-AMP by several folds did not extend the length of this hypometabolic state. Giving 
additional 5’-AMP when an animal was about to arouse led to high mortality after the mouse 
had been in hypometabolism for 14-18 hours. However, animals that have returned to 
euthermia can undergo another episode of 5’-AMP induced hypometabolic state without the 
observed mortality outcome. Thus, my research aim was to investigate the physical, 
biochemical and physiological parameters that control the process of deep hypometabolism 
in mice. The hypothesis was that by understanding these parameters, the limitations of the 
non-hibernator’s ability to maintain deep hypometabolism for prolonged periods could be 
expanded by administering key supplement(s). Through this expansion, we may allow non-
hibernators to perform a deep hypometabolic process observed only in nature by hibernators.  
At the biochemical level, we began by obtaining a detailed metabolic analysis of serum 
metabolites of the animals at 4 distinct stages. These 4 stages, as defined by Heldmaier, are 
4 
 
entrance, maintenance, arousal and euthermia. However, since our animals are induced, the 
entrance samples were taken as euthermic samples prior to induction to establish a baseline 
to compare the later samples. At the physiological level, the core body temperature and the 
metabolic rate of the animals were examined via telemetry and oxygen consumption/carbon 
dioxide production during these 4 stages (Figure 1). The oxygen consumption (VO2) graph 
revealed 2 distinct phases of deep hypometabolism present in every mouse that is injected 
with 5’-AMP. The first phase (PI) is the induction or entrance phase, portrayed by the steep 
and rapid drop in VO2 from euthermic levels (~4000 ml /kg/h) to around 1500 ml/kg/h. The 
second phase (PII), characterized by the gradual decline from 1500 ml/kg/h VO2 to about 
300 ml /kg/h, is the stage in which deep hypometabolism is achieved, followed by the 
maintenance phase. The arousal phase is characterized when the VO2 displays a steady 
increase from the basement level reached during the maintenance phase where VO2 
surpasses 2000 ml/kg/h. The recovery phase is started when the animal is back to euthermic 
temperature with VO2 levels of ~ 4000 ml/kg/h. A telemetry device implanted in the mouse 
allowed us to simultaneously monitor the relation between the core body temperature and 
that animal’s oxygen consumption (VO2). At the physical level, the effect of environmental 
temperature on the physiological response of the mice during the hypometabolic state was 
investigated. My studies revealed several important conclusions: 1) The environmental 
temperature plays a major role in modulating the outcome of deep hypometabolism.  2) The 
dosage of 5’-AMP plays a key role only during the initial induction stage of 
hypometabolism, but not its prolonged maintenance. 3) Our biochemical analysis revealed 
that there are dramatic changes between the 4 behavioral stages in the flux of key 
metabolites which play a role in glycolysis/gluconeogenesis, transamination, purine  
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Figure 1. Normal mouse data of induced hypometabolism by 5’-AMP. The top graph 
represents oxygen consumption (VO2) while the bottom is the correlated core body 
temperature (CBT) graph. After an injection of 5’-AMP, the mouse exhibits a quick and 
immediate drop in oxygen consumption (Phase 1) followed by a more gradual decrease 
(Phase 2). The 4 stages that the blood samples were collected for the Metabolon study that 
will be talked about later are labeled on the CBT graph. 
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 catabolism and bile acids but fatty acid metabolism is less pronounced. 4) My studies 
investigate whether the supplementation of certain metabolites in combination with fluid 
could extend the length of hypometabolism in the mice. 
 A brief introduction to purine metabolism is provided to give some perspective to the 
fate of the 5’-AMP injected. The 5’-AMP that is used to induce hypometabolism is primarily 
metabolized to Inosine monophosphate (IMP) via AMP deaminase while there is a minor 
pathway that catabolizes 5’-AMP by dephosphorylation to adenosine using AMP 
nucleotidase. The 5’-AMP is also salvaged via the adenylate equilibrium to form ADP by 
utilizing ATP.  Once 5’-AMP returned back to physiological levels, the ADP can then be 
reconverted back to ATP through the adenylate equilibrium. We have experimental evidence 
to indicate that the major pathway via AMP deaminase and the conversion to ADP are the 
main events in metabolizing the 5’-AMP injected to induce this DH state.  
Glucose is usually broken down via glycolysis ultimately producing pyruvate and lactate in 
times of oxidative stress. The lactate can be recovered back to pyruvate by lactate 
dehydrogenase once it is transported to the liver. The pyruvate feeds into the TCA cycle 
after conversion to Acetyl-CoA. Throughout both of these processes, energy is stored as 
NADH, FADH2 and ATP. However, in the red blood cells, glycolysis is the primary 
biochemical process to generate NADH and ATP. Oxidative phophorylation in combination 
with glycolysis and the TCA cycle help make glucose a very efficient producer of energy; 1 
glucose molecule is accepted to make around 38 ATP after it is completely metabolized. 
When the body is able, glucose is the preferred fuel source for its efficient ability to produce 
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energy. However, there are instances when glucose in limited and other fuel sources must be 
utilized. One of these alternative fuel sources comes from amino acid catabolism. Amino 
acids are different in their structure from glucose due to the amine group they possess. For 
the most part, both glucose and amino acids are hydrocarbons (consisting of hydrogen and 
carbon atoms) and therefore can both be readily used to produce energy. The difference is 
that the amine group on amino acids must be taken care of once it is free from its carbon 
chain. This is primarily done by removal from the body through the urea cycle since 
ammonia is highly toxic at high levels. Amino acids are described as either ketogenic 
glucogenic or both based on where they are utilized in producing energy. Glucogenic amino 
acids can generate net glucose when it is metabolized. In contrast ketogenic amino acids 
may not generate net glucose. Most amino acids are both ketogenic and glucogenic. All the 
amino acids except for leucine and lysine are glucogenic which means the carbon skeleton 
of these amino acids can be used in the production of gluconeogenic precursons like 
pyruvate and TCA cycle intermediates like oxaloacetate and alpha-ketoglutarate. The two 
purely ketogenic amino acids above give rise to acetyl-CoA and acetoacetyl-CoA which can 
produce energy via the TCA cycle however they cannot be used directly in gluconeogenesis. 
Once the amine group is removed it must be discarded which is done mainly by the urea 
cycle which is responsible for taking ammonia out of the cells and removing it after being 
processed in the liver and filtered through the kidneys. The importance of these pathways 
will be examined further throughout this body of work to give a better idea of the metabolic 
changes occurring in the mice while in the DH state. 
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CHAPTER TWO 
Methods 
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Female C57BL/6 mice from either Taconic Farms or Harlan were used in the current 
studies; however, the induction of DH has been shown to be just as effective in male and 
female mice. Fresh 9-12 week old mice were given a few weeks rest in our animal facilities 
with a 12h/12h Light Dark (LD) cycle to adjust to their new environment before being used 
for the proposed studies. In addition, mice that have undergone DH were rested for a few 
weeks before being reused in order to allow them to regain any lost body weight from the 
procedure.  
The laboratory instrument used in the current studies is a reverse flow climate 
controlled metabolic chamber from Columbus Instruments, USA. It is a temperature-
controlled incubator with 16 individually monitored cages with their own access to food and 
water. Each cage has its own monitoring device for oxygen consumption and CO2 
measurements. The information is then stored in an on-board computer that also controls the 
entire instrument.  
First, an experimental regime was established to keep things consistent in order to 
define the effects of changing the desired parameters. From previous experimentations 
undertaken by the laboratory, it has been observed that a temperature at about 15oC was 
desirable. Thus, the thermostat was set at 14.5oC; in the metabolic chamber, the ambient 
temperature (Ta) at this setting is actually right around 15oC based on the readings from a 
thermometer placed in the chamber. Mice are nocturnal, therefore experiments were initiated 
at around 5 a.m. All mice were fasted for 12h but water is given ad labitum. For the fasting, 
the mice are removed from their normal cage and put into a fresh cage with fresh bedding 
and water. By putting them into a fresh cage, there is no possibility of food crumbs, 
droppings or deposits from prior feedings on the floor that could be a source of food. It is 
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not known if fasting plays an intricate role in either the suppression and/or the survival of 
the mice; it is done as a means to normalize the experiments and to eliminate unknown 
variables that could have an impact on the proposed study. Before the mice are placed in 
their respective cages in the metabolic chamber, they are weighed so the computational 
software can calculate the appropriate measurements (VO2, VCO2, etc.) during the 
experiment. Once the mice are in their respective cages, the experiment is set up by giving 
the experiment a label or file name, inputting animal tag numbers and their weights for the 
respective cages, and, when telemetry (Mini-Mitter Respironics, OR, USA) is used, the 
associated telemetry chip number with that mouse is also entered. The machine is then 
calibrated with a sample gas with predetermined concentrations of oxygen and carbon 
dioxide, and the experiment is ready to begin collecting data. After a few initial readings 
lasting for about 30 minutes to gather baselines of all the mice, hypometabolism is initiated 
with an intraperitoneal injection containing freshly prepared 5’-AMP (Sigma catalog # 
A1752-25G) [0.5 mg/g body weight] in 100uL saline. As will be demonstrated later, the 0.5 
mg/gw is an efficient dose of initiating the deep hypometabolic process resulting from a 5’-
AMP titration.  The saline is made from OmniPur tablets (EMD chemicals product code 
6501). 1 tablet is dissolved per 100uL water for a 1X solution and then pH adjusted to 7.2 
and autoclaved to sterilize. Before injection, the saline is filter sterilized (.22µm sterile 
syringe filters from Fisherbrand No. 09-719A). The first injection of tested metabolite was 
given 2 hours after the 5’-AMP injection chilled on a bucket of ice for 30 minutes prior. The 
injections between the initial 5’-AMP injection and the injections after the temperature is 
bumped up were all given chilled to administer a solution closer to that of their body 
temperature. The metabolites that will be tested in this study are glucose (Sigma D – (+) – 
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Glucose, G-8270), pyruvate (Sodium Pyruvate SigmaUltra P8574-100g), arginine (Acros 
Organics, L(+)- Arginine 104991000) and alanine (B-Alanine Eastman 4638). The 
injections were of a similar volume of saline as a control for each experiment. The 
concentration of metabolite, volume injected and frequency of metabolite given would vary 
depending on the hypothesis being tested. In addition, the Ta would be changed to test the 
effects of temperature on arousal and to establish a rewarming protocol that would allow for 
a safe return to euthermia after mice have been in DH for a prolonged period. Throughout 
the experiment, if mice aroused they would be taken out into normal room temperature and 
placed back into their original cages with food and water ad labitum. After the experiment 
was concluded, all remaining mice would be removed and put into their respective cages to 
be monitored for the next 1-2 days. If mice appeared to be in any discomfort, they were 
euthanized after symptoms were observed and noted. All experiments were carried out in 
accordance with protocols approved by the animal welfare committee at the UTHSC 
medical school (HSC-AWC-06-078 and HSC-AWC-08-015). 
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CHAPTER THREE 
Results 
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Effect of 5’-AMP dosage on deep hypometabolism 
We have been able to mimic the torpor process, in both metabolic rate depression 
and body temperature depreciation, in our laboratory with the administration of 5’-AMP. 
Previous studies by other members of the laboratory revealed that a deeper torpor state can 
be attained if the mice given 5’-AMP are cooled to a lower core body temperature. This 
deep torpor behavior, which we call deep hypometabolism (DH) or “suspended animation”  
(SA) has physiological parameters such as core body temperature and metabolic rate based 
on oxygen consumption that are much lower than natural torpor (Heldmaier et al., 2004). In 
general, it was observed that when a mouse’s core body temperature (CBT) drops below 
18oC, it lost the ability to right itself when laid on its side or back, thereby entering our DH 
or SA state. The length of time the mice are usually maintained in the DH state is currently 
about 3-9 hours on average.  
To demonstrate that the 5’-AMP concentration is the initiator of the process and not 
the driver responsible for prolonging deep hypometabolism, mice were injected with a single 
dose of 5’-AMP ranging from 0mg to 1mg per gram body weight (mg/gw) and then kept in 
Ta of about 15oC.  As seen in Figure 2, the length of time in the deep hypometabolic state, 
where core body temperature is below 17oC and VO2 is below 1000 ml/kg/h, is independent 
of the amount of 5’-AMP used once an efficient dose (at least 0.5mg/gw) is reached that will 
ensure entrance into deep hypometabolism at 15oC Ta. As discussed previously, each mouse 
that is injected with 5’-AMP, regardless of the dose, exhibits the initial phase 1 drop in VO2 
but the phase 2 maintenance of DH is not apparent when the dosage of 5’-AMP is  
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A)    C)  
              
 
B)   D)  
           
 
 
 
Figure 2. 5’-AMP titration. Mice were injected with A) Saline, B) .1mg / gram body 
weight (mg/gw), C) .5mg/gw and D) 1.0 mg/gw all at 15o ambient temperature (Ta). B) Also 
shows the injection of 5’-AMP and the corresponding phase 1 and 2 (PI and PII) to show 
that even low concentrations of 5’-AMP respond similarly and therefore the concentration is 
only important to induce the process, not to prolong it. All VO2 readings are in hundreds. 
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insufficient. This observation suggests that the concentration of 5’-AMP is necessary to 
cross the threshold and initiate the process. Once the mouse enters DH, the timing of arousal 
is not dependent on the dose of 5’-AMP used to induce DH. In addition, previous studies 
from other members of the laboratory have investigated whether arousal could be 
suppressed by re-injecting another dose of 5’-AMP. Logically, the process should be 
repeatable until the investigator decides to end the experiment and allow the mouse to 
arouse. However, what was observed was that suppression of arousal by additional injection 
of 5’-AMP led to increased mortality. It was observed that mice in DH after 14h have high 
mortality rate when arousal was suppressed by additional injections of 5’-AMP. The cause 
of death remains unclear, although dehydration is one possibility.  Therefore, dehydration as 
a cause of death during prolonged DH was investigated.  
Does giving saline during DH increase survival and help suppression of arousal? 
Hibernators can spend weeks at a time in hibernation, which allows their bodies to 
go without food and, more importantly, without water for longer periods than is normally 
possible (Heldmaier et al., 2004). However, it has been observed that hibernators that 
undergo bouts of arousal during winter rise to drink but not to eat during their episodes of 
euthermia (McManus 1974). Since these mice are not natural hibernators, it was 
hypothesized that they may need certain supplements to maintain their deep hypometabolic 
state. The first supplement to test is the most important for sustaining life, water; but, in 
order to keep electrolyte levels at physiological norms, saline instead of water was used for 
these studies. The experiment was basic; one group of mice (n=8) received periodic 
injections of saline; another group of mice (n=8) received mock injections, during which 
they were taken out and handled, then subsequently returned to their cages. After about 18h 
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in DH, both groups of mice were aroused by raising the Ta to ~16oC. One of the mice from 
the group not given fluid did rise before 12h and was excluded from the final analysis.  The 
findings from this experiment are as follows: 5 of the 8 mice given saline survived, although 
2 of these 5 mice had aroused spontaneously from DH at about 14 h. Only 1 of the 7 mock-
injected mice survived (Table 1). After 12h, no mock-injected mice aroused and none 
survived. This experiment indicated that hydration for the mice in the DH state was 
beneficial. However, given that about half of the animals did not survive, it suggests that 
hydration alone is not enough. In addition, of the mice that died, some displayed apparent 
neurological defects, such as involuntary movements after they had re-warmed, and they 
were euthanized.   
Fresh vs. reused mice 
After performing multiple experiments, an apparent trend was observed between 
arousal rate and whether the mice were fresh (animals that had not been injected with 5’-
AMP) or reused (mice that had been given 5’-AMP previously). Suppression, at the same 
temperature, seemed to favor mice that had never been administered 5’-AMP over those that 
had been used in an experiment regardless of whether this previous experiment was a week, 
a month or even months ago. When these data sets were examined, it proved that my initial 
observations were correct: the mice that were seeing 5’-AMP for the first time typically 
have a much lower rate (15%) of early arousal (arousal before 12h) when saline is provided 
after mice had entered DH. In contrast, mice that were being reused and had seen 5’-AMP 
before have a much higher rate of early arousal (51%) (Table 2). It was noticed that many of 
these early arousals appeared to be the heavier animals in the group. Therefore, the  
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Saline injections while in DH 
 
 
No Saline injections 
 
 
5/8  mice survived after 12h 
 
 
1/7 mice survived after 12h 
 
 
Table 1. Saline vs. Non-Saline Mice. Each group (n=8) were used to test the importance of 
saline. At ~15oC mice in the saline group were injected periodically while the non-saline 
mice were handled similarly to the saline treated mice without receiving an injection. 1 
mouse from the non-saline group came out before 12 hours and therefore was not included 
in the final analysis. 
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Fresh mice arousal rates  
(in first 12 hours) 
Given saline  
 
 
Reused mice arousal rates  
(in first 12 hours) 
Given saline  
 
 
3/20 = 15%  
 
 
20/39 = 51% 
 
 
Table 2. Arousal rates between fresh and reused mice. Arousal rates in fresh and reused 
mice were examined to explore an observational trend. After examining the data, there 
seems to be a preference for the fresh mice to stay down in DH after 12 hours. Experiments 
were all run around 15oC with periodic injections of saline. 
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relationship between mouse weight and the time of spontaneous early arousal with the 
reused mice was examined. When the arousal time of the mice in DH given saline was 
plotted against their body weight, a trend was visible (Figure 3). Smaller mice tend to stay 
down longer than bigger mice. One possible explanation of this relationship could exist in 
the cooling efficiency between the smaller and larger animals.  The larger animals have a 
smaller surface to volume ratio, which may not allow them to cool to a lower core body 
temperature as the smaller ones, and therefore they may not have fallen into as deep DH as 
the smaller mice. However, it is possible that other factors could be involved, since some of 
the early arousal animals were small. Nevertheless, the data would suggest that larger mice 
may need to be cooled in a slightly lower temperature than the smaller mice.  
Does the circadian cycle have any influence on arousal? 
The mice used in these experiments are typically housed in a 12h/12h light dark 
(LD) cycle in the animal facilities. However, some studies on natural hibernators conduct 
their research in 12h/12h Dark/Dark (DD) to coerce the animals into their hibernating bouts 
(Heldmaier et al., 2004). To address whether this change in environmental signal was 
important for preventing early arousal of mice in DH, a group of mice (n=16) with many 
habitual early arousals was put in a DD cycle for 3 days prior to DH induction.  An earlier 
study with this group of mice when kept in an LD cycle showed that many were habitual 
early risers (Figure 4). As can be seen from the graph, about half of the 16 mice came out 
from DH during the first 12 hours. The same group of mice now maintained in a DD cycle 
did not show a significant reduction of early arousal.  The LD and DD results with this 
group of mice revealed that the number of early arousals were similar at about 50% (Figure 
4). Therefore, there is no apparent effect of the DD cycle on the suppression of early arousal.   
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Figure 3. Examination of relationship between weight and arousal time. 19 reused 
saline mice were induced into DH and their arousal times were recorded and plotted against 
their weight to examine if there is a trend. Whereas a trend was apparent, showing that 
heavier mice tend to come out earlier than the lighter ones, some light ones also came out 
early suggesting there are other factors influencing arousal other than weight. Statistical 
analysis done by software from Wessa, 2008. 
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Figure 4. Role of Circadian Cycle in suppressing arousal. The same 4 saline mice were 
used once in a normal 12h:12h Light Dark (LD) cycle and then again in a 12h:12h Dark 
Dark (DD) cycle weeks later to test if there was a benefit to doing our studies in DD instead 
of LD. After examining the data, there did not seem to be any significant difference in 
suppression of arousal. 
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However, it was observed that in the few DD experiments that were run, the survival after 
12 hours was impressive – 14 out of 16 mice that stayed beyond 12h survived. Many of 
these were in DH for 18h or longer. This is an interesting observation that will need to be 
explored further in the future. 
Effects of environmental temperature on deep hypometabolism 
The role played by environmental temperature in determining the length of the DH 
state was investigated. Previous studies have suggested that environmental temperature is a 
key exogenous factor in regulating hibernation (Al-Badry and Taha, 1982). Two groups of 
mice (n=4) were given the same dose of 5’-AMP (.5mg/gw) but were maintained at different 
ambient temperatures: 23oC and 15oC. Figure 5 shows the effects of 5’-AMP induced 
hypometabolism at these two different ambient temperatures. The results show that the 
length of time the animal spends in deep hypometabolism is much longer when the ambient 
temperature is 15oC than at 23oC. Furthermore, the 15oC graph shows that the depth of DH 
attained and the severity of metabolic suppression were increased at this lower temperature 
when compared to the 23oC graph. Given that the same dose of 5’-AMP was used for both 
groups of mice, it can be concluded that at the lower temperature, the DH is prolonged and 
arousal further suppressed compared to the warmer Ta.   
To further support these findings, an investigation was carried out to determine 
whether arousal from DH could be suppressed completely by further lowering the Ta.  To 
exclude the possible contribution of individual mice variability, the same group of inbred 
mice (n=5) was used in sequential fashion for this study. When given 5’-AMP (0.5mg/gw), 
the same group of mice were maintained at ambient temperatures of 13.8oC, 13.6oC, 13.4oC 
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Figure 5. Effects of Environmental Temperature on DH. Mice were injected with .5 
mg/gw 5’-AMP and placed at 2 different environmental temperatures, ~23oC and ~15oC. 
Each group also has the phase 1 and phase 2 of induction labeled to point out the differences 
between the 2 temperatures. At 23oC, the phase 2 drop is short and approaches 1000 VO2 
before the mouse starts to come out from DH about 2 hours later. However at 15oC, the 
phase 2 drop is more pronounced and lower allowing the mice to stay in DH for up to ~10 
hours. This experiment showed that the environmental temperature is the important factor in 
suppressing arousal for the DH state. 
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or 13.2oC. The VO2 graphs in Figure 6 show that there is a correlated linear relationship 
between the arousal rate of these mice and the Ta. The suppression of arousal is evident; not 
only do more mice stay down as the temperature is decreased, but the mice that come out do 
so significantly later than at the warmer temperatures.  
From these results, subsequent experiments with fresh mice using a Ta of 13.2oC 
were undertaken. The suppression of arousal results were similar; however, the fresh mice 
were met with an astonishingly high mortality rate after 12h (>95%) even when saline was 
provided.  Therefore, this strategy for preventing early arousal in mice needs to be 
investigated further.  
In conclusion, the current investigation revealed that DH of mice can be induced by 
5’-AMP. The amount of 5’-AMP only controls whether or not the mice will enter DH; the 
Ta is the key parameter regulating the DH state. If kept at about 15 oC, mice will safely enter 
DH and remain in such a state for about 3-9 hours following an injection of 5’-AMP of the 
appropriate dose.  
One objective of this research is to extend the limit of DH in the mice. The above 
studies have shown that lowering the ambient temperature, giving injections of saline while 
in DH and administering an additional injection of 5’-AMP at the first sign of arousal all 
have significant drawbacks to their ability to extend the DH length. Primarily, it increases 
the mortality rate when Ta is too low after the mice have stayed in DH for more than 14 
hours, even when saline was given. Additional injection of 5’-AMP prevented normal 
arousal but also enhanced mortality rate. 
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Figure 6. Temperature Titration. A group of 5 mice were used in subsequent experiments 
to establish a temperature that was beneficial to completely suppressing arousal. The 
temperatures ranged from 13.8 – 13.2 in .2oC increments. The experiment showed that as the 
temperature is decreased, arousal is delayed and in some cases inhibited altogether.  
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Changes in metabolites during various stages of 5’-AMP mediated hypometablism 
To gather some insight into the changes of the metabolic state when mice undergo 
deep hypometabolism, serum was obtained from mice (each group n=8 mice) during the 4 
stages; euthermia (control), deep hypometabolism (SA), arousal (reverse flip) and full 
recovery (recovery). These serum samples were examined at a commercial company 
specializing in metabolite analysis (METABOLOM). Figure 7 illustrates the 4 different 
behavioral stages where the mice were sacrificed and their serum collected and how the 
metabolomic data was analyzed. For each group, the value of each metabolite is the average 
obtained from 8 mice. For each of the metabolites, the average value at euthermia is 
arbitrarily set at 1.  The fold change in the DH, arousal and recovery is relative to the value 
obtained for euthermia. Therefore, a value of 1 indicates no change, a higher value indicates 
an increase and a value less than 1 indicates a decrease, all relative to euthermic levels.  
Is glucose important in suppressing arousal? 
The findings from the metabolomic analysis indicate that serum glucose was 
maintained at an elevated level for a prolonged period during DH (Figure 8). It has also 
been noted that a genetic shift from glycogen and fatty acid synthesis to gluconeogenesis is 
occurring in hibernating arctic ground squirrels, suggesting the animals are trying to provide 
themselves with increasing amounts of available glucose during their hibernation bouts 
(Yan et al., 2008).  In addition, previous observations from the laboratory suggest that 
arousal coincides with decreased blood glucose and the activated expression of pro-colipase 
in the liver and other peripheral organs (Zhang et al., 2006). The metabolomic study also 
shows that glucose decreases between the DH state and arousal (reverse flip) state. It has  
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Figure 7. Example of Metabolon Data. This is an example of how to read future figures 
that came from a Metabolomic Study done by Dr. Zhaoyang Zhao. Each group of mice 
(n=8) had blood collected at the 4 time points which were labeled in Figure 1. Control was 
prior to induction of DH, SA state is while in DH, Rev Flip is upon spontaneous arousal, and 
Recover is after the mice have returned to euthermia.  
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Figure 8. Glucose Metabolon data. Shows the levels of Glucose and Glucose-6-Phosphate 
through the different stages of DH. As can be seen, both are highly elevated from control 
groups with a slight drop in glucose between DH (SA State) and spontaneous arousal (Rev 
Flip) which could signify an inability to produce large amounts of glucose anymore 
signaling arousal to the mouse.  
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further been suggested that hibernating ground squirrels use the increased availability of 
glucose to fuel their body’s non-shivering thermogenesis (NST) maintaining their body at 
the right temperature while in hibernation (Yan et al., 2008). Together, this information led 
to a hypothesis that the mice may arouse when they can no longer produce the large amounts 
of glucose they need to sustain themselves in the DH state. Thus, whether injecting glucose 
could suppress arousal better than saline alone was investigated. Two groups of mice (n=3) 
were injected with similar amounts of saline at the same intervals; however, one group 
received glucose (20mg) at the 2-hour injection. After that injection, subsequent injections 
were solely saline for both groups. The experiments revealed that two mice from each group 
came out from DH at roughly 8-9 hours while the last of the saline group came out around 
12-13 hours and the last of the glucose group around 20 hours after an increase in the 
temperature. Overall, the studies revealed that there was no major differential outcome in 
preventing early arousal whether the mice received saline or glucose (Figure 9). Additional 
experiments confirmed the conclusion that the early arousal rates continued to be about 
equal between glucose-injected mice and saline-injected mice. One possible reason for the 
elevated blood glucose is that the overall rate of glycolysis had been slowed at hexokinase 
and phosphofructose kinase, since there is also a 4-fold build-up of glucose 6-phosphate and 
fructose 6-phosphate according to the Metabolomic data. 
Is pyruvate important for suppressing arousal? 
Consistent with a reduced rate of glycolysis, the Metabolomic data indicated 
extremely low pyruvate and lactate levels in the DH state (Figure 10). Lactate is utilized by 
the liver to make pyruvate. Pyruvate is normally converted by pyruvate dyhydrogenase to 
acetyl-CoA, a necessary input for the TCA cycle. However, ground squirrels undergoing  
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Figure 9. Glucose experiment. 2 groups of mice (n=3) were either given an injection of 
glucose or pure saline around 2 hours into the experiment followed by subsequent injections 
of saline. There appeared to be no benefit in suppressing arousal by injecting glucose over 
just saline.  
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Figure 10. Glycolytic Products Reduced in DH. Metabolon data shows that there is a 
decrease in the glycolytic products of pyruvate and lactate while there is also an increase in 
glycolytic intermediates. This would point to either a reduction in glycolysis or an increase 
in gluconeogenesis.   
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torpor have shown an overexpression of Pdk4 (pyruvate dehydrogenase kinase isoform 4), 
an enzyme that deactivates pyruvate dyhydydrogenase, blocking the conversion of pyruvate 
to acetyl-CoA (Yan et al., 2008). In addition, in the liver, pyruvate can also be converted 
into oxaloacetate (OAA) then to malate which can exit the mitochondria and be used for 
gluconeogenesis by producing phosphoenolpyruvate. Interestingly, it has been recently 
shown that a key enzyme for the aforementioned process, Phosphoenolpyruvate 
carboxykinase (Pck1), is overexpressed in hibernating bears while some glycolytic enzymes 
are underexpressed, also hinting toward a state of gluconeogensis during hibernation 
(Fedorov et al., 2009). It is also interesting that some TCA cycle intermediates, such as α-
ketoglutarate, isocitrate and succinate, were also dramatically decreased (Figure 11). 
Slowing the TCA cycle causes the body to resort to a glycolytic state for ATP generation. 
Glycolysis is highly inefficient compared to oxidative phosphorylation where ATP is 
produced from the electron transport chain. 
 It is possible that the reduction in the TCA cycle intermediates could be a direct 
result of the decrease in pyruvate availability, since its absence could cause a slowdown in 
acetyl-CoA production that in turn would limit the amount available for the TCA cycle. 
Thus, supplemental pyruvate injected into the mice may restart the TCA cycle, which will in 
turn enhance the oxidative phosphorylation process allowing the mice to produce energy 
much more efficiently. Therefore, whether giving pyruvate to mice in DH might suppress 
arousal and prolong the amount of time down was investigated. Two groups of mice (n=3) 
were given either saline or pyruvate after they had entered DH after treatment with 5’-AMP. 
Similarly to the glucose experiment, the pyruvate group got the supplemental injection 
(20mg) at 2h and saline at subsequent injections. The study showed that there was no  
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Figure 11. TCA cycle intermediates reduced in DH. Metabolon data shows that there is a 
decrease in a few TCA cycle intermediates hinting at a slowing down of the TCA cycle in 
the DH state. 
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significant suppression of early arousal between the mice given saline and those given 
pyruvate (Figure 12). This result was fairly similar to that of the glucose experiment; 
however, the 3 mice from each group came out before or around 12 hours. The outcome of 
this experiment and several other subsequent larger studies indicated that pyruvate did not 
alter the level of early arousal, nor did it result in better survival compared with saline when 
animals stayed down for longer than 12 hours.  Thus, it is concluded that a deficiency in 
pyruvate was not a major factor in regulating early arousal. 
Are amino acids important to suppressing arousal? 
Additional reevaluation of the Metabolomic data revealed that the mice had a very high 
level of glucose and glucose 6-phosphate while in DH. In the liver, glucose 6-phosphate is 
converted to glucose. However, in the muscle glucose and glucose 6-phosphate can be 
converted to glycogen for storage or used in glycolysis to generate ATP. Furthermore, 
during DH, other glycolytic intermediates like phosphoenolpyruvate (PEP) were increased 
(Figure 13). However, the products of glycolysis such as pyruvate and lactate were 
decreased. The increase in glycolytic intermediates, combined with the decrease in pyruvate 
and lactate, suggested that the mice were possibly undergoing gluconeogenesis or that 
glycolysis was highly reduced while in the DH state. Similarly, it has been shown recently 
that arctic ground squirrels have increased gene expression of gluconeogenic enzymes in 
their torpor state when compared to euthermic levels (Yan et al., 2008). Lactate is normally 
produced in the muscle when oxidative phosphorylation cannot sustain the demand for 
cellular ATP leading to anaerobic ATP generation via glycolysis. However, the mice 
displayed much lower levels of lactate, suggesting that there is actually very little demand 
for glycolysis. In addition, the extremely low levels of pyruvate also suggested that the level  
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Figure 12. Pyruvate Experiment. 2 groups of mice (n=3) were either given pyruvate or 
saline 2 hours into the experiment followed by saline for all mice in following injections. 
This experiment shows, similarly to glucose, that there is no real difference in arousal rates 
between saline and pyruvate injected mice.  
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Figure 13. Later glycolytic intermediates increased in DH. Metabolon data shows an 
increase in late stage glycolytic intermediates.   
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of glycolysis was low. This may explain why blood glucose and glucose 6-phospate is 
significantly enhanced in the mice during DH. 
If the hypothesis that the mice are in a gluconeogenic state is correct, then synthesis 
of glucose will require the availability of carbon skeletons, which are provided by amino 
acids, lactate or glycerol.  The metabolomic data indicated that the catabolites of amino 
acids were significantly increased during DH suggesting that amino acids were indeed 
catabolized (Figure 14). Some genes in the liver, Glud1 and Got2, responsible for amino 
acid catabolism have also been shown to be overexpressed during torpor in ground squirrels 
(Yang et al., 2008). Therefore, whether giving amino acids to supplement the energy 
production would help suppress arousal was investigated. 
 In order to determine which of the amino acids to use, a serum panel was run of 
amino acid levels in normal mice (n=2), mice in DH (n=2) and mice at arousal (n=2) 
through a commercial service laboratory at Baylor College of Medicine. This study revealed 
that the mice in DH and at arousal were low in two amino acids, histidine and arginine, 
while the rest of the amino acids were greatly enhanced or not affected during DH and at 
arousal compared with euthermic control (Table 3). Table 3 shows the complete panel with 
the two reduced amino acids indicated by the arrow. Each group of mice (euthermic, in DH 
and at arousal) had 2 sample points with the average value taken of those points and 
displayed in bold below the group. The most significant reduction is arginine. Why 
arginine? 
To answer this question, the biological pathways that these amino acids are involved 
in were examined; importantly, arginine plays an intricate role in the urea cycle (Figure 15).  
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Figure 14. Amino Acid catabolites are increased in DH. Metabolon data shows an 
increase in amino acid catabolic products in DH.  
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Table 3. Amino Acid assay. An amino acid assay from mouse serum samples (n=2) taken 
at 3 different stages throughout DH. First stage was euthermic (normal), second was while 
in DH (SA) and the third was at initial sign of spontaneous arousal. The 2 amino acids that 
are decreased are pointed out (histidiine and arginine).  
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Figure 15. Urea cycle. NAGS, N-acetylglutamate synthetase; CPS1, carbamylphosphate 
synthetase 1; OTC, ornithine transcarbamylase; AS, argininosuccinate synthetase; AL, 
argininosuccinate lyase; citrin, mitochondrial aspartate-glutamate carrier; ornithine transport 
system. The urea cycle displays the intricate role that arginine plays in the functionality of 
the entire cycle. 
 
 
The reduction in the availability of arginine may compromise the urea cycle’s ability to 
release urea and regenerate ornithine, which is essential to transport the NH2+ group on the 
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carbarmoyl-phosphate out of the mitochondria by forming citrulline. Therefore, a shortage 
of arginine could significantly reduce the animal’s ability to deal with an increased ammonia 
build up generated by transamination of amino acids (Figure 16). Since it requires more 
energy to produce uric acid than ammonia, the natural tendency would leave the ammonia 
groups as ammonia. Ammonia is highly reactive with lipids in plasma membranes, resulting 
in severe cellular damage; however, it is only toxic in the brain (Walker, 2009). Hibernating 
bears have means to recycle their nitrogenous waste, decreasing their urea cycle outputs 
(Barboza et al., 1997). The decrease in activity of the urea cycle noticed in the bears has 
also been shown in hibernating ground squirrels (Williams et al., 2005), which suggests all 
natural hibernators have an ability to suppress urea formation while in a hibernation-like 
state. Since these mice are not natural hibernators, they potentially do not possess these 
mechanisms to prevent the build-up of ammonia. Because of this possible inability to handle 
increases of ammonia while in DH, the mouse’s ability to stay in DH for a prolonged time 
may be limited. It is possible that mice spontaneously arouse to handle the build-up of 
ammonia. To help gain insight into this theory, a colleague (Isadora Susan Daniels, Ph.D. 
student) in the lab ran a blood urea nitrogen assay (QuantiChrom™ Urea Assay Kit, DIUR-
500 from Bioassay Systems) for mice throughout the DH process; the time points (n=20) 
were pre-injection, 1 hour into DH, 4h into DH, spontaneous arousal (RF), shivering, and 
return to euthermic temperature (Figure 17). The data shows a steady increase over the 
course of DH, with a decrease at the spontaneous arousal stage. This could suggest that the 
urea cycle is indeed shut down in the DH process, causing an accumulation of nitrogen in  
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Figure 16. Breakdown pathways of amino acids. Shows possible options in removing 
ammonia after the breakdown of amino acids. In the case of our mice, which it is 
hypothesized the urea cycle is compromised during DH, this figure suggests that the 
ammonia being produced would stay as free ammonia causing a build-up in vivo.  
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Figure 17. Accumulation of blood urea nitrogen. Corroborating evidence from a member 
in the laboratory shows an increase of blood urea nitrogen (BUN) levels throughout the DH 
process with a slight decrease at the signal of spontaneous arousal (RF). Blood sampes were 
taken from mice (n=20)  in the different stages of DH (SA). This data lends some merit to 
our hypothesis of the urea cycle being compromised from the decrease in arginine 
throughout the DH process. 
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the blood. The spontaneous arousal could be a signal to the body that blood nitrogen levels 
are reaching a critical mass and the animal must come out to get rid of the waste. This result 
supported our theory and thus, it was investigated whether supplementing arginine could 
suppress early arousal. Two groups of mice (n=4) were used; one received an injection of 
arginine (2mg) at the 2h injection (same as pyruvate and glucose), and subsequent injections 
were pure saline for the rest of the experiment. Figure 18 shows that the effect of arginine 
was striking. It was observed that 3 of the 4 mice that received arginine did not arouse early. 
None of the saline- injected mice (n = 4) displayed a similar ability to prolong DH. Not only 
was the early arousal suppressed, the survival after 12 hours was improved. The three 
arginine-injected mice that stayed down after 12h were able to stay in DH for up to 24 
hours, and all survived without complications. 
The hypothesis was made that the arginine had repaired the urea cycle; it has been 
shown previously that arginine can be used as an alternate pathway treatment to repair some 
urea cycle deficiencies in human patients (Walker, 2009). To investigate this hypothesis, 
another amino acid, alanine, was tested for a similar outcome. The transamination of alanine 
with α-ketoglutarate via alanine transaminase is directly converted into glutamate and 
pyruvate, one of the metabolites that is in very short supply during DH (Strobel 2007). If 
the mice given alanine showed similar results to the arginine mice, it could be inferred that it 
was not the urea cycle being repaired but simply that an amino acid fuel source was what the 
mice needed. A group of 7 mice (4 alanine, 3 saline) were given their respective injections 
2h into the experiment. This experiment showed that giving alanine to mice only slightly 
increased the amount of time mice stayed in DH compared to saline-injected animals 
(Figure 19). However, the suppression was not nearly as dramatic as the arginine, and most  
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Figure 18. Arginine vs. saline experiment. 2 groups of mice (n=4) were given either saline 
or an injection of arginine 2 hours into the experiment and subsequent saline injections to 
both groups. This experiment suggested that arginine was beneficial in suppressing arousal 
and of those it suppressed the survival was better. The 4 saline mice all came out before or at 
12 hours whereas only 1 arginine mouse came out before 12 hours and one lasted almost 24 
hours in DH. 
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Figure 19. Alanine vs. saline experiment. 2 groups of mice (n=4 alanine and n=3 saline) 
were given either saline or an injection of alanine 2 hours into the experiment. The alanine 
injected animals lasted slightly longer in DH however most still aroused by 12 hours and the 
one that stayed down more than 15 hours wound up coming out with fatal side effects. 
Suggested that alanine could not be used in suppressing arousal. 
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of the mice still came out as early arousals, meaning arousal was not completely suppressed. 
Also, those that stayed down for more than 14-15 hours came out with unwanted side effects 
that affected their long term viability. These side effects include an inability to balance 
properly and constant shaking; these animals were euthanized. Descriptions of these side 
effects have been noted before in human cases dealing with arginase deficiencies (Brusilow 
et al., 2001), and it has also been noted that urea cycle deficiencies in general can lead to 
brain damage (Walker, 2009). These experiments suggested that the amino acids are 
important, however arginine’s effect on the urea cycle appears to be crucial for both 
suppression and survival. Normally small hibernating rodents use their amino acids to 
produce energy through gluconeogenesis and the TCA cycle since these amino acids are not 
producing urea (Yang et al., 2008), however since these mice are being induced into this 
torpor-like state and do not prepare their bodies like typical hibernating animals (Al-Badry 
and Taha, 1982), the arginine given may aid in removing the nitrogenous waste that is 
being produced. In order to confirm arginine’s importance, the successful experiment’s 
parameters were repeated with all 16 mice given arginine (2mg). They all received an 
injection at 2h into DH and another arginine injection at the 28h mark for the mice still 
down. The intermediate injection was saline. Figure 20 shows that the results from the 
initial experiment were highly replicable and further proof of the significance and 
effectiveness arginine has on the arousal rates and survival of the mice. All mice but 2 
stayed down for the initial 12 hour period and upon an increase in temperature and removal, 
all mice came out and survived. One unfortunate fatality was due to human error a few days 
post experiment; however, I believe it could have been readily prevented if the right 
precautions had been taken. In addition, this study revealed that 2 mice were in DH for 30  
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Figure 20. Arginine experiment. All mice (n=16) were given an injection of arginine 2 
hours into the experiment. 2 mice came out in the first 12h however suppression was largely 
suppressed and there was 100% survival even for those mice that stayed down 28+ hours.  
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hours and when they were gradually rewarmed, they returned to euthermic state without 
obvious disabilities. Typically, from observations of many past experiments, if mice stay in 
DH after the temperature is bumped up they do not survive even for a day. These mice, 
however, were viable and appear normal even after 3 weeks of monitoring after undergoing 
this 30-hour DH. This experiment has since been repeated and similar results were obtained. 
Therefore, it has been concluded that at least part of the reason for arousal is tied to a build-
up of ammonia in vivo. The ammonia build up is a consequence of the transamination of 
amino acids as the animal in DH is undergoing gluconeogenesis. A shortage of arginine 
compromised the animal’s ability to safely remove the ammonia through the urea cycle. By 
arousing early, the gluconeogenic process would slow as the normal oxidative 
phosphorylation process to generate ATP returns and the production of ammonia is reduced.   
Is any single metabolite better than the rest? 
After a multitude of experiments using the metabolites above, all the data was pooled 
together and examined. From this data, 2 tables were created, providing an in-depth analysis. 
The first table shows the various metabolites and their benefit to suppress early arousal 
(Table 4). Even though some sample sizes were smaller than others, one metabolite stands 
out: arginine. Its 14% total arousal rate is half that of the next closest (pyruvate) and 
significantly less than saline alone (39%). The second table shows the overall survival after 
being in DH for 12 hours for the different groups of mice (Table 5). This is the most 
interesting data of all. While most of the metabolites are right around saline (58% saline, 
64% glucose and 67% pyruvate), once again arginine is superior. The difference is 
phenomenal. Of the arginine mice that stayed down 12 hours or more, 94% survived. This  
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Metabolite Arousal before 12h
Saline 23/59 = 39%
Glucose  5/16 =  31%
Pyruvate 25/89 = 28%
Arginine 6/42 = 14%
 
Table 4. Metabolite benefit for suppressing arousal. Table shows the metabolite and their 
corresponding percentage of mice that were early arousals (before 12h). Arginine had the 
best at 14% which was half of the next closest and almost a third of saline.  
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Metabolite Overall Survival after 
12h
Saline 21/36 = 58%
Glucose 7/11 = 64%
Pyruvate 43/64 = 67%
Arginine 34/36 = 94%
 
Table 5. Metabolite benefit for survival after 12h. Table shows the metabolite and their 
corresponding percentage of mice that survived after 12 hours in DH. Arginine is a clear 
favorite at 94%. The 2 deaths in the arginine group are believed to have been preventable 
since they were both due to human error during or after the experiment.  
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number would have been 100%; however; the two animals that did succumb died due to 
human error after having aroused from DH. 
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CHAPTER FOUR 
Discussion 
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The fate of the 5’-AMP injected is the focal point around this study. Our studies 
revealed that 5’-AMP can be disposed of in 2 different ways; it can be catabolized to IMP 
and/or adenosine or it can be converted via the adenylate equilibrium to 2 ADP by 
combining with an ATP. The latter is the aspect believed to be important in the DH initiation 
process. Since ATP is essential for maintaining cellular activity levels at their optimum, by 
injecting AMP and removing ATP it would cause a slowdown in cellular functional levels 
throughout the body. Where this could possibly be of the utmost importance is in the red 
blood cells where their sole source of energy is the ATP dependant process of glycolysis. 
Our studies revealed that the red blood cells take up 5’-AMP readily. In turn, the increased 
intracellular 5’-AMP will force the adenylate equilibrium to form 2ADP utilizing the 
cellular ATP pool decreasing the level of intracellular ATP levels. Reducing ATP levels will 
affect glycolysis at two critical steps where ATP is required. The first is at hexokinase where  
glucose is converted to glucose 6 phosphate. The second is at phosphofructokinase which 
converts fructose 6 phosphate to fructose 1,6 bisphosphate. The observed rise in glucose, 
glucose 6-phosphate and fructose 6-phosphate is consistent with a stalling of glycolysis at 
hexokiase and at phosphofructokinase.  Metabolic modeling studies have shown that a 
decrease in ATP production in the RBC will lead to an increased production of 2,3 
bisphosphoglycerate causing an increase in oxygen’s disassociation with hemoglobin. This 
is consistent with the phase I profile where a rapid decline in oxygen consumption was 
observed and is independent of the animal’s core body temperature and the dosage of 5’-
AMP given. In turn, the decrease in oxygen transport will slow down peripheral cell’s 
metabolic needs by reducing oxygen availability.  When the body cools, the demand for 
oxygen also decreases thereby creating and interdependent loop between metabolic need and 
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oxygen availability. This could explain the phase II profile where oxygen consumption was 
linked to the animal’s body temperature.  
These investigations of how the arousal process can be controlled have revealed 
several interesting findings. If no fluid is provided, very few mice will stay in the deep 
hypometabolic state beyond 12h under a permissive arousal temperature (Ta of 15oC). We 
classified arousal before 12h as early arousal for the remainder of this discussion. If arousal 
is suppressed by lowering the Ta to 13.2oC, then the mortality rate is increased if arousal 
from deep hypometabolism is blocked for more than 12h. When saline is provided during 
the DH state under Ta of 15oC, about 40% of the mice would be early arousals but, 
significantly, about 60% of the mice can remain in DH longer than 12h. It was observed that 
freshly bought mice that have not seen 5’-AMP previously have an early arousal rate of 15% 
compared with 50% for reused mice. Given that the reused mice were typically heavier, we 
investigated whether there was a relationship between the size of the mice and early arousal. 
Plotting the weight of the mice against its arousal time revealed a relationship between early 
arousal and the size of the animals. However, some of the smaller mice also displayed early 
arousal, suggesting that weight and size alone cannot explain early arousal and endogenous 
factor(s) are likely involved in the triggering of arousal. 
  While giving saline alone suppressed arousal for about half the mice in our study 
group (combining new and reused mice), mortality rate is still about 40% of those that 
stayed in DH longer than 12h. Whether optimizing the amount of fluid given over a 24h 
period could reduce this mortality rate is unclear. Rather, it was hypothesized that fluid 
alone is not enough to prevent death in mice that remain in DH longer than 12h. Through 
metabolic studies that have identified changes in metabolites, a series of experiments were 
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explored to test the usefulness of glucose (highly elevated in DH) and pyruvate (highly 
decreased in DH) in suppressing arousal. Giving glucose to mice (20mg/inj) had a 31% early 
arousal rate and about a 64% survival rate for the mice that stayed in DH longer than 12h. 
This was not much better than giving saline to the mice. It indicated that glucose is neither a 
major regulator of early arousal nor a metabolite that could improve survival when DH was 
prolonged.   
Pyruvate is slightly better than glucose (28% versus 31% early arousal rate) at 
suppressing early arousal.  About 67% of the mice given pyruvate that stayed in DH longer 
than 12h survived; this number too was right around that of glucose. The outcomes for 
pyruvate, glucose and saline were very similar in suppression of early arousal and overall 
survival rate after DH longer than 12 h.   
To date, the most promising metabolite that showed a major differential outcome in 
suppression of early arousal and decreased mortality of mice in DH after 12h is the amino 
acid arginine. Mice given arginine have the lowest level of early arousal (14%) and 
mortality rate of mice in DH longer than 12h (6%). In fact, we have 3 mice that were in DH 
for 30h and they all survived without apparent neurological damage. We have attributed this 
success to arginine’s role in the urea cycle; however, arginine is also a key component in 
creatine production and in nitric oxide production (Walker, 2009). The urea cycle and nitric 
oxide pathway actually have many other intermediates and enzymes in common other than 
just arginine (M.A. Neill et al., 2009). The urea cycle and NO pathway share arginine, 
citruline, argininosuccinate, aspartate, argininosuccinate synthetase (AS) and 
argininosuccinate lyase (AL) as well as a transporter, Citrin. Whereas the urea cycle has 
parts in both the cytoplasm and the mitochondria, NO production takes place solely in the 
57 
 
cytoplasm. From our current studies, it appears that the urea cycle is the key player in the 
survival and long term DH of our mice. However since the urea cycle and the NO pathway 
are intertwined and seem to regulate each other (M.A. Neill et al., 2009), we will have to 
examine both pathways to clarify their contribution to suppressing arousal. It has been 
hypothesized that short term regulation of the urea cycle takes place in the mitochondria at 
the enzyme CPS1 (Carbamoyl Phosphate Synthetase I), which is responsible for taking the 
ammonia groups out of the mitochondria and transferring them into the urea cycle when 
carbamoyl phosphate combines with ornithine (Walker, 2009). This enzyme has also been 
shown to be down regulated in hibernating bears (Fedorov et al., 2009). Since arginine 
plays a role not only directly in the urea cycle but also in the formation of a cofactor, NAGS, 
of carbamoyl phosphate production (Walker, 2009), if arginine is reduced as it is in our 
model, it would shut down both the shuttling out of ammonia from the mitochondria and the 
production of urea. In the future, there are proposed studies to investigate enzymatic genes 
of the urea cycle to determine which, if any, genes are being down regulated and/or up 
regulated throughout our DH process. There have been studies that show supplemental 
arginine, in instances of increased arginase activity that had led to human diseases such as 
asthma and pulmonary arterial hypertension, has been beneficial for treatment (Morris et 
al., 2008). There are other treatments besides arginine that have been effective in treating 
urea cycle deficiencies via alternate pathways (Walker, 2009), but it has been suggested that 
arginine may have advantages over other drugs (Jobgen et al., 2006). For future 
investigations, we plan to inject these drugs (Sodium Benzoate and/or Sodium 
Phenybutarate), or citruline (Walker, 2009) as it removes an ammonia group while also 
getting converted to arginine which could help replace the reduced amount of arginine in 
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vivo. Such studies, if successful in prolonging arousal, would give support to our current 
findings that the inability to regulate ammonia is the primary cause for early arousal and 
mortality if DH is prolonged. 
After considering the urea cycle and its role, we must also examine the NO pathway 
for its redundancy in intermediates and enzymes with the urea cycle. The production of NO 
has numerous vital biological roles (Nathan, 1992) as it has 3 differentially expressed 
isoforms: the endothelial (eNOS) isoform primarily regulates vascular tone, the inducible 
(iNOS) isoform is mainly present in inflammatory and infectious conditions, and the 
neuronal (nNOS) isoform is mainly in neuronal tissue acting as a signaling molecule (M.A. 
Neill et al., 2009). It has also been suggested that NO plays a role in regulating nutrient 
metabolism in almost all types of mammalian cells and tissues (Jobgen et al., 2006) 
whether it is used in the cell that produces it or whether the NO gets taken up by the red 
blood cells and transported to distant target cells (Stamler and Meissner, 2001). The 
synthesis of NO requires more inputs than just arginine; it also requires tetrahydrobiopterin 
(BH4), NADPH, Ca2+, calmodulin, FMN and FAD (Wu and Morris, 1998). NADPH and 
calmodulin are need to give the NOS isoforms enzymatic activity while the Arginine, BH4 
and heme are all used as promoters and stabilizers (Wu and Meininger, 2002). Since NO is 
a highly reactive free radical species, it can have various affects depending on the 
concentration (Jobgen et al., 2006). At physiological levels, NO stimulates glucose uptake 
and oxidation, fatty acid oxidation, mitochondrial biogenesis, while enhancing lipolysis and 
ATP concentration and inhibiting synthesis of glucose, glycogen and fat (Jobgen et al., 
2006). However if physiological levels are exceeded, it can disrupt the electron transport 
chain (ETC), resulting in reduced ATP from oxidative phosphorylation and causing an 
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increase in glycolysis to produce the required ATP. High levels of NO also decrease protein 
synthesis while increasing amino acid catabolism (Jobgen et al., 2006). Since the NO 
pathway and urea cycle are dependent upon each other, they must have mechanisms in place 
to regulate one another and provide feedback to make sure the NO pathway does not exceed 
the physiological levels and become a detriment to the cells. It has been suggested that NO 
may reduce expression of urea cycle enzymes and urea synthesis from ammonia while 
inhibiting amino acid oxidation in the liver and increasing the amount of dietary amino acids 
released into the circulation (Jobgen et al., 2006). In order to keep a balance on the NO 
production, the urea cycle can increase its rate in order to limit necessary substrates like 
arginine (M.A. Neill et al., 2009). These feedback mechanisms appear to be crucial in 
keeping each other in check. While it has been shown that arginine increases transcription of 
NOS and NO production (Jobgen et al., 2006), if our mice were running out of arginine, it 
was assumed these pathways would also be shut down in addition to the urea cycle. 
Supplying arginine has been shown to have numerous effects on both humans and test 
animals. In diabetic rats, it has been shown to reduce plasma levels of glucose, fatty acids 
and triglycerides (Jobgen et al., 2006) while also reducing fat mass and showing promise in 
uses for treating metabolic disorder (Flynn et al., 2002). In humans, it has been shown to 
increase insulin sensitivity (Jobgen et al., 2006). Therefore, it has been hypothesized that 
supplementing arginine, and maybe even citruline, might be able to help in treating 
metabolic disorder (Jobgen et al., 2006) as well as potentially saving our mice. These are 
testable hypothesis for future studies. 
In summary, the following is what is believed to be occurring in this hypometabolic 
model. After induction by injection of 5’-AMP and placement at ~15oC Ta the urea cycle is 
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slowed and possibly halted due to a depletion of arginine levels. Therefore, the animals’ 
ability to remove ammonia from the body is deficient, leading to a build-up of free ammonia 
in the blood. The spontaneous arousal that is seen is probably due to a critical limit in 
ammonia levels in the blood acting as a signal to the animal to arouse or die. Therefore, by 
supplementing the various other metabolites, we were not addressing the critical problem 
that existed while the animals were in DH and that is why the other metabolites did not 
work. Only once the urea cycle’s importance and in vivo arginine levels were addressed did 
the mice start to prolong their time down in DH safely and consistently.  
For future experiments, there are a few directions to test the various ideas to support 
our current data. The urea cycle enzymes should be compared between DH, euthermia and 
arousal to see if there are any changes. Citruline, Sodium Benzoate and/or Sodium 
Phenybutarate can be substituted for arginine to evaluate if it is in fact the urea cycle 
(Walker, 2009). If these treatments have similar effects to the arginine, that would point to 
the urea cycle as being deficient in our mouse model. We can also take blood ammonia 
levels during a time course throughout the DH process to see if there is an accumulation of 
free ammonia as time elapses. Unlike the previous data which measured blood nitrogen 
levels, this measurement would be solely for free ammonia and not total nitrogen levels. To 
test whether the NO pathway is the reason for the arousal and the lack of long-term survival, 
previous studies have used NO donors to treat NO deficiencies caused by an arginine 
shortage (Morris et al., 2008). By giving one or more of these donors to our mice, if the 
outcome is similar to the arginine experiments, we could suggest that the shortage of 
arginine and the consequences of our DH state were impacting the NOS pathways and not 
the urea cycle.  
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